TMO Thermo Fisher Scientific

company

SEC Filings & Insider Trading Activity 2026

Management Discussion & Analysis

• • Revenue $44,556M, up ~3.9% YoY from $42,879M; Lab Products & Biopharma Services largest segment at $23,984M
• • GAAP operating margin 17.4% vs 17.1%; adjusted operating margin 22.7% vs 22.6%; driven by productivity gains offset by tariffs and mix

Business Overview

• • Core business: Life sciences tools & services conglomerate serving pharma/biotech, academic, industrial, and healthcare markets across four segments
• • Sept 2025 acquisition of Solventum's filtration/separation business (~$4.04B total acquisition spend in 2025) added bioproduction purification tech plus industrial filtration for battery, semiconductor, and medical device markets

Risk Factors

• • China regulations requiring local suppliers plus tariff volatility directly threaten international revenues, with currency translation adding $0.37B to 2025 revenues
• • Outstanding debt ~$39.38B with $5.00B revolving credit facility; covenant requires minimum 3.5:1.0 Consolidated Net Interest Coverage Ratio

Management Discussion & Analysis

• • Revenue $11,122M Q3 2025, up $524M YoY from $10,598M in Q3 2024
• • GAAP operating margin 17.4% Q3 2025 vs 17.3% Q3 2024; Adjusted margin 23.3% vs 22.3%

Risk Factors

• • No material changes to risk factors since 2024 10-K filing

What are the latest TMO SEC filings in 2026?

Thermo Fisher Scientific (TMO) has filed a 10-K annual report on February 26, 2026, a 10-Q quarterly report on October 31, 2025, an 8-K current report on April 23, 2026 with the SEC. SignalX tracks every new SEC EDGAR filing daily, including 10-K, 10-Q, 8-K, and Form 4 insider transactions, with AI-powered summaries of key sections.

When did TMO file its most recent 10-K annual report?

Thermo Fisher Scientific (TMO) filed its most recent 10-K annual report on February 26, 2026. The 10-K includes audited financial statements, business overview, risk factors, and management discussion, all available on SignalX with AI-generated summaries and XBRL financial data.

How do I view TMO 10-Q quarterly reports?

Thermo Fisher Scientific (TMO)'s most recent 10-Q quarterly report was filed on October 31, 2025. SignalX displays every TMO 10-Q with AI-generated summaries of the MD&A (Management Discussion & Analysis) and Risk Factors sections, plus links to the original SEC EDGAR document.

What 8-K current reports has TMO filed recently?

Thermo Fisher Scientific (TMO)'s most recent 8-K was filed on April 23, 2026. 8-K filings disclose material corporate events such as earnings releases, executive changes, mergers, and other significant developments. SignalX surfaces each 8-K with item-level summaries so you can quickly see what happened.

Where can I find TMO insider trading activity (Form 4)?

SignalX aggregates every TMO Form 4 insider transaction from SEC EDGAR. Form 4 reports show when officers, directors, and 10% shareholders buy or sell company stock, with transaction code, share count, and price per share.

How often does TMO file with the SEC?

Thermo Fisher Scientific (TMO) files a 10-K annual report once per year (typically within 60 days of fiscal year-end) and 10-Q quarterly reports three times per year. 8-K current reports are filed as needed when material events occur, and Form 4 insider transaction reports are due within two business days of a trade. SignalX monitors SEC EDGAR daily to surface every new TMO filing with AI-powered analysis.

What is the difference between 10-K, 10-Q, and 8-K SEC filings?

A 10-K is a comprehensive annual report with audited financials, business overview, and risk factors. A 10-Q is a shorter quarterly report with unaudited financials and management discussion. An 8-K is a current report filed when a material event occurs — such as earnings releases, executive changes, acquisitions, or other significant developments. SignalX provides AI-generated summaries for all three filing types for Thermo Fisher Scientific (TMO).

What is TMO's SEC CIK number?

Thermo Fisher Scientific (TMO)'s SEC CIK (Central Index Key) number is 97745. The CIK is a unique identifier assigned by the SEC to every filing entity. You can use CIK 97745 to look up all TMO filings on SEC EDGAR, or browse them here on SignalX with AI-powered analysis.

Where can I find TMO return on equity (ROE) and financial data?

SignalX extracts XBRL financial data from Thermo Fisher Scientific (TMO) 10-K annual filings, including revenue, net income, gross profit, operating income, EPS, total assets, stockholders' equity, and operating cash flow. Return on equity (ROE) can be derived from net income divided by stockholders' equity. Multi-year financial trends are displayed in the Financial Summary table above.